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ABSTRACT
The increased use of Chinese herbal products (CHPs) worldwide has raised the concern of herb–drug interactions. The aim of this study 
was to determine the prevalence and utilization patterns of concurrent use of conventional drugs and CHPs in Taiwan. The usage and 
frequency of services in the co-prescription of a CHP and a conventional drug were evaluated. Subjects were recruited from a simple 
random sample of 1,000,000 subjects from over 22 million beneficiaries of the National Health Insurance in 2007. The logistic regression 
method was employed to estimate the odds ratios (ORs) for the co-prescription of a CHP and a conventional drug (CH + D) and a 
conventional drug alone (D-alone). The prevalence of the CH + D was 14.1%. Females, regular salary earners, and elderly (65 years 
and above) were more likely to consume a CHP and a conventional drug concurrently. Painkillers, especially acetaminophen, and 
anti-cough medicines were the top two conventional drugs that were most frequently co-prescribed with a CHP. Anti-cough medication 
is the most common conventional drug co-prescribed with CHP, after painkillers. We recommend that safety issues be investigated 
in future research and integrating both healthcare technologies may be beneficial for the overall health and quality of life of patients.
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INTRODUCTION
Even with modern medical advances, Chinese herbal prod-
ucts (CHPs), which have been used as traditional medicine in 
China, Japan, and Korea for over thousands of years, continue 
to be widely used for health maintenance, disease prevention, 
and even disease treatment.[1] Furthermore, in many developed 
countries, CHPs are becoming increasingly popular, and the world 
expenditure on CHPs is not only large but also growing rapidly.[1] 
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Therefore, a CHP and a conventional drug are likely used concur-
rently. Recent studies have indicated that the majority of people 
do not tell their physicians about the co-utilization of conventional 
drugs and CHPs.[2-4] The concurrent use of conventional drugs and 
CHPs will increase the risk of potential herb–drug interactions oc-
curring due to the interference in the pharmacokinetics of the first 
drug.[5-10] Cytochrome P450 (CYP450) enzymes are responsible 
for more than 50% of the metabolism of not only painkillers in 
our body but also of CHPs like Corydalis Rhizoma (延胡索 Yán 
This is an open access article under the CC BY-NC-ND license.
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Hú Suǒ) and Salviae Miltiorrhiza Radix (丹參 Dān Shēn).[11-13] 
The inhibition of CYP450 because of concurrent CHP use may lead 
to increased drug plasma level and toxicities. A study reported that 
concurrent use of conventional drugs and herbal products was found 
in 15% of patients and there were nearly 40% potential adverse 
herb–drug interactions among these patients.[14] However, few stud-
ies have been performed to survey the prevalence of co-utilization 
between conventional drugs and CHPs, and previous studies might 
introduce recall bias due to the nature of self-reporting surveys.[15,16]
Traditional Chinese Medicine (TCM) as a unique traditional 
therapy for various ailments has also been used in Taiwan for over 
hundreds of years, and its popularity remains unabated despite 
the modernization of medical care in Taiwan. In addition, one 
distinguishing feature of the national healthcare system is the 
co-existence of the modern conventional medicine and TCM (in-
cluding acupuncture, chiropractic, and CHP), which has been 
regularly reimbursed by the National Health Insurance (NHI) in 
Taiwan since 1995.[17-20] Also, people in Taiwan are free to visit 
conventional medicine clinics or TCM clinics. Thus, the NHI 
research database provides an ideal platform for a pharmaco-
epidemiological study of this field. This study aimed to explore 
the demographics and utilization patterns of how frequent is the 
concurrent use of conventional drugs and CHP on a nationwide 
level in real practice. We believe that this study would provide 
evidence-based information for formulating appropriate manage-
ment strategies of drug safety and integrative medicine.
MATERIALS AND METHODS
Data resources
This study was commenced after obtaining approval from 
the review board of the Committee on Chinese Medicine and 
Pharmacy, Department of Health, Taiwan. It was designed as a 
cross-sectional analysis of a random sample of 1,000,000 subjects 
out of 22 million beneficiaries of the NHI of Taiwan to determine 
the national prevalence of co-prescription of CHP and conventional 
drugs. All data were obtained from the National Health Insurance 
Research Database (NHIRD), which included all the reimburse-
ment data of the NHI transformed and maintained by the National 
Health Research Institutes of Taiwan.[21] The identification numbers 
of all individuals in the NHI database were encrypted to protect 
the privacy of the individuals. For research purposes, the NHIRD 
had selected a random sample of 1 million subjects from the 22 
million insured population, which contained their medical record 
files, including medical care facilities and specialties, drugs and/
or management for treatment, patient’s gender and date of birth, 
date of visiting, transferred identification number, and three major 
diagnoses coded in the International Classification of Diseases, 
9th Revision, Clinical Modification (ICD-9-CM) format.[22] Both 
TCM doctors and conventional doctors must follow the standard 
diagnoses of using the ICD-9-CM coding system when claiming 
reimbursement.
Study sample
As all the prescribed conventional drugs are covered under 
the NHI of Taiwan, no drug could be dispensed at a pharmacy 
without a doctor’s prescription. To construct a fixed cohort, we 
included the patients who were prescribed conventional drugs 
from the random sample of 1 million individuals. TCM is one of 
the oldest healing systems in the world and has been followed in 
Taiwan for over hundreds of years. Its practice includes CHPs, 
acupuncture, and traumatology manipulative therapies; these are 
reimbursed by the NHI of Taiwan. For the purpose of studying 
combined prescriptions of a CHP and a conventional drug in the 
present study, we downloaded the claim forms for reimbursed 
CHPs from the website of the Bureau of NHI. The corresponding 
herbal information about a specific mixture or name was then 
obtained from the Committee on Chinese Medicine and Phar-
macy (CCMP) website, including the names of each herb and the 
herbal formulae, the proportions of each constituent, the date and 
period of approval as drug, code and name of manufacturer given 
by CCMP. For simplicity, all CHPs with the same CCMP standard 
formulae are classified under the same categories, regardless of 
the slight variations among products of different pharmaceutical 
companies.[23] The variables of a co-prescription of a CHP and a 
conventional drug for analyses were defined based on the CHP and 
the conventional drug that were prescribed to one individual on the 
same day. Figure 1 illustrates the prevalence of the co-prescription 
of a CHP and a conventional drug in the study cohort from 1997 
to 2007. This prevalence seems to have stabilized around 1998, 
although it does demonstrate a slight increase since 2003. We, 
therefore, selected 2007, the most up-to-date year, to simplify 
our analysis. The final fixed cohort consisted of 859,102 users of 
conventional medicines. Among them, we further categorized the 
types of preparation used as follows: 738,373 were prescribed a 
conventional drug alone (D-alone) and 120,729 were co-prescribed 
a CHP with a conventional drug (CH + D).
Study variables
To understand the key independent variables affecting the 
utilization of a co-prescribed CHP and conventional drug among 
users of conventional medicines, we selected the demographic 
factors according to previous studies.[19] In addition to gender, 
age of the subjects was categorized into nine groups: 0-4, 5-14, 
15-24, 25-34, 35-44, 45-54, 55-64, 65-74, and 75 years or older. 
Registry for regions was also used to determine the major predic-
tors of the co-prescription group. We split the monthly income into 
three levels: 0, NT$ 1-9999 and ≥ NT$ 10,000 (1 US$ =29 NT$).
Statistical analysis
Data analysis was undertaken using descriptive statistics, 
including the prescription rates of either D-alone or CH + D 
stratified by patient’s age and gender, the population distribution, 
the frequencies of the disease categories prescribed with D-alone 
and CH + D, and the most frequently prescribed herbs. We also 
carried out statistical analysis of the database to compare the 
characteristics between CH + D and D-alone groups. The logistic 
regression method was used to estimate the odds ratios (ORs) for 
CH + D and D-alone groups. A significance level of α =0.05 was 
selected. The most common indications or diagnoses for CH + D 
group were evaluated. The classification of primary indications 
was according to the ICD-9-CM. We considered the first diagnosis 
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as the major diagnosis in the outpatient clinic, which was coded 
in ICD-9 in the NHIRD and then grouped into broader disease 
categories. For example, ICD-9 codes of 460-519 were classified 
as diseases of the respiratory system; codes 780-799 were grouped 
as symptoms, signs, and ill-defined conditions; and codes 520-579 
were classified as diseases of the digestive system. The statistical 
software SAS 9.13 was used for data management and analyses.
RESULTS
The outpatient claims database for 2007 contained information 
on 859,102 users of conventional medicines with 10,309,191 pre-
scriptions. During the prescription period of conventional medicine, 
14.1% (120,729) of the users also received 402,570 prescriptions of 
CHP on the same day at least once, given by the TCM doctors, of 
whom 94.3% had worked at local TCM clinics. Approximately 95% 
of the prescriptions for the concurrent use of a conventional drug 
and a CHP were for a period of no more than 8 days. Details on the 
demographic distribution of concurrent use of CH + D and D-alone 
are provided in Table 1, which shows that the mean age of the CH + D 
population was slightly higher than that of the D-alone population.
Adjusted OR and 95% confidence intervals (95% CIs) resulting 
from the logistic regression model are presented in Table 2. After 
adjusting for other factors, the OR of female patients (CH + D: 
OR 1.60; D-alone: OR 1.16) was higher than that of males (OR 
1.00) to be a concurrent user. Compared with the 25-34 years age 
group (OR 1.00), the OR of the CH + D increased with age to a 
peak in the 65-74 years age group (OR 1.49), whereas the ORs of 
D-alone group became relatively high only in the over 55 years 
age groups (≥ 75 years age group: OR 6.48). Unlike the behavior 
of the children’s usage of a conventional drug, the OR of children 
using a combination of a CHP and a conventional drug was less 
than that of 25-34 years age group (OR 1.00).
As compared to patients living in Northern Taiwan (OR 1.00), 
the ORs of CH + D for patients living in Central, Southern, and 
Eastern Taiwan were 1.78, 1.42, and 1.18, respectively, whereas 
those of D-alone for patients living in Central, Southern, and 
Eastern Taiwan were 0.69, 0.96, and 1.06, respectively. As ex-
Figure 1. Prevalence of co-prescriptions of Chinese herbal products and conventional drugs among the cohort of users of conventional medicine at 
the outpatient departments, 1997-2007
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Table 1. Demographic characteristics of patients who co-prescribed 
Chinese herbal products and conventional drugs (CH + D) or 
conventional drug alone (D-alone) from the 1 million random sample 
of the National Health Insurance Research Database, 2007
Variables Total (N) CH+D 
patients n (%)
D‑alone 
patients n (%)
Total 859,102 120,729 14.1 738,373 85.9
Age†
Mean (years) 37.1 41.1 36.5
0-4 32,133 3091 9.6 29,042 90.4
5-14 121,083 12,359 10.2 108,724 89.8
15-24 123,703 12,580 10.2 111,123 89.8
25-34 140,222 18,636 13.3 121,586 86.7
35-44 135,636 21,044 15.5 114,592 84.5
45-54 128,982 22,094 17.1 106,888 82.9
55-64 79,939 14,529 18.2 65,410 81.8
65-74 55,554 10,437 18.8 45,117 81.2
≥75 41,850 5959 14.2 35,891 85.8
Gender
Male 410,032 45,600 11.1 364,432 88.9
Female 449,070 75,129 16.7 373,941 83.3
Region
Northern Taiwan 430,116 49,497 11.5 380,619 88.5
Central Taiwan 158,655 29,351 18.5 129,304 81.5
Southern Taiwan 251,118 39,303 15.7 211,815 84.3
East Taiwan 19,189 2576 13.4 16,613 86.6
Monthly income
0 356,650 43,768 12.3 312,882 87.7
NT$ 1-9999 80,646 11,416 14.2 69,230 85.8
≥NT$ 10,000 421,806 65,545 15.5 356,261 84.5
†Refers to patient’s age on 1 January 2007
Lai, et al. / Journal of Traditional and Complementary Medicine 3 (2013) 256‑262
259
pected, the ORs of patients with monthly income in excess of 
NT$ 10,000 (CH + D: OR 1.02; D-alone: OR 1.12) were more 
likely to combine CHPs and conventional drugs than those with 
no income (OR 1.00).
On analysis of the percentage distribution of 859,102 users of 
conventional medicines, we found the diseases of the respiratory 
system (630,773) were the most frequent major disease category, 
followed by diseases of the digestive system (347,483) and dis-
Table 2. Adjusted odds ratios and 95% confidence intervals for the characteristics associated with the utilization of co-prescribed Chinese herbal 
products and conventional drugs (CH+D) and conventional drug alone (D-alone) in Taiwan, 2007
Characteristic CH+D P value D‑alone P value
Sex
Male 1.00 1.00
Female 1.60 (1.58-1.63)* <0.0001 1.16 (1.11-1.21) <0.0001
Age (years)
0-4 0.72 (0.69-0.75) <0.0001 17.26 (12.07-24.68) <0.0001
5-14 0.76 (0.74-0.78) <0.0001 2.59 (2.36-2.85) 0.0012
15-24 0.74 (0.72-0.75) <0.0001 1.20 (1.11-1.29) <0.0001
25-34 1.00 1.00
35-44 1.20 (1.18-1.23) <0.0001 0.83 (0.79-0.88) <0.0001
45-54 1.35 (1.32-1.38) <0.0001 0.98 (0.93-1.05) <0.0001
55-64 1.45 (1.42-1.49) <0.0001 1.63 (1.50-1.77) <0.0001
65-74 1.49 (1.45-1.53) <0.0001 3.26 (2.86-3.70) <0.0001
≥75 1.10 (1.06-1.13) 0.0005 6.48 (5.31-7.91) <0.0001
Region
Northern Taiwan 1.00 1.00
Central Taiwan 1.78 (1.75-1.81) <0.0001 0.69 (0.65-0.72) <0.0001
Southern Taiwan 1.42 (1.40-1.44) <0.0001 0.96 (0.92-1.01) 0.029
East Taiwan 1.18 (1.13-1.24) <0.0001 1.06 (0.91-1.22) 0.0088
Monthly income
0 1.00 1.00
NT$ 1-9999 0.98 (0.96-1.01) 0.0099 1.02 (0.94-1.10) 0.2767
≥NT$ 10,000 1.02 (1.00-1.04) 0.0003 1.12 (1.05-1.18) <0.0001
*Odds ratio (95% confidence interval)
Table 3. Subjects’ and frequency distribution of the co-prescribed Chinese herbal medicine and conventional drugs (CH+D) and conventional 
medicine alone (D-alone) at outpatient visits stratified by major disease categories (according to ICD codes) in Taiwan, 2007
Major disease category ICD‑9‑CM 
code range
Total CH+D D‑alone
n (%) n (%)
Total 859,102 120,729 14.1 738,373 85.9
Diseases of the respiratory system 460-519 630,773 104,144 16.5 526,629 83.5
Diseases of the digestive system 520-579 347,483 74,212 21.4 273,271 78.6
Diseases of the nervous system and sense organs 320-389 313,214 61,535 19.6 251,679 80.4
Symptoms, signs, and ill-defined conditions 780-799 283,835 81,570 28.7 202,265 71.3
Diseases of the skin and subcutaneous tissue 680-709 260,085 50,206 19.3 209,879 80.7
Diseases of the musculoskeletal system and connective tissue 710-739 210,071 53,580 25.5 156,491 74.5
Injury and poisoning 800-999 203,867 42,286 20.7 161,581 79.3
Diseases of the genitourinary system 580-629 167,580 44,599 26.6 122,981 73.4
Infectious and parasitic diseases 001-139 133,693 25,220 18.9 108,473 81.1
Diseases of the circulatory system 390-459 126,462 27,805 22.0 98,657 78.0
Endocrine, nutritional, and metabolic diseases, and immunity 
disorders
240-279 76,719 17,404 22.7 59,315 77.3
Mental disorders 290-319 54,626 14,470 26.5 40,156 73.5
Supplementary classification V01-V83 39,534 7715 19.5 31,819 80.5
Neoplasms 140-239 34,877 7937 22.8 26,940 77.2
Complications of pregnancy, childbirth, and puerperium 630-677 11,306 2496 22.1 8810 77.9
Diseases of the blood and blood-forming organs 280-289 6691 2187 32.7 4504 67.3
Congenital anomalies 740-759 3282 946 28.8 2336 71.2
Certain conditions originating in the perinatal period 760-779 701 135 19.3 566 80.7
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eases of the nervous system and sense organs (313,214) [Table 3]. 
As for the prevalence rate of either concurrent use of conventional 
medicine and CHP or use of D-alone with respect to the major 
disease categories, compared with the patients suffering from dis-
eases of the respiratory system (OR 1.00), patients with diseases 
of the blood and blood-forming organs were associated with a 
2.46-fold (95% CI 2.33-2.59), patients with congenital anomalies 
had 2.05-fold (95% CI 1.90-2.21), and patients with diseases of the 
symptoms, signs, and ill-defined conditions had 2.04-fold (95% CI 
2.02-2.06) increase in the use of a CHP and a conventional drug.
As Table 4 shows, acetaminophen, dextromethorphan, diclof-
enac, ibuprofen, and ambroxol were the top five most frequently 
combined prescribed conventional drugs with CHPs. Details on 
the most frequently prescribed herbs are also provided in Table 4, 
which shows that Corydalis Rhizoma (延胡索 Yán Hú Suǒ) was 
the most frequently prescribed herb, followed by Fritillariae Bulbus 
(貝母 bèi mǔ) and Salviae Miltiorrhiza Radix (丹參 Dān Shēn). 
Supplemented Free Wanderer Powder (加味逍遙散 Jiā Wèi Xiāo 
Yáo Sǎn) was the most frequently prescribed formula, followed by 
Pueraria Decoction (葛根湯 Gé Gēn Tang) and Channel‑Coursing 
Blood‑Quickening Decoction (舒筋活血湯 Shū Jīn Huó Xuè Tang).
DISCUSSION
High prevalence of co‑prescription
This survey provides evidence that the co-prescription of a 
CHP and a conventional drug has a relatively high prevalence 
(14.1%) in Taiwan. To the best of our knowledge, this study is the 
first of its kind using a random national-level sample to document 
the use of CHP concomitant with prescription medicines. It is in-
teresting to note how simultaneously conventional medicine was 
used among TCM users when the expenses of the conventional 
medicine and CHPs are both reimbursed by the NHI system in 
Taiwan.[17-20] This system allowed all beneficiaries choosing either 
conventional medicine or TCM freely to relieve their discomfort 
and/or diseases, resulting in a high insured rate of 99% of the 
Taiwanese population who have joined the NHI program.[17,21] 
Therefore, the estimated prevalence rate presented here is close 
to the true concomitant use of CHP and conventional drug in 
Taiwan. Moreover, unlike recall bias, which can be introduced 
by self-reporting surveys,[15,16] all patients in the present study 
who suffered from some degree of discomfort or a disease were 
prescribed CHP by licensed TCM doctors and conventional 
drugs by doctors of conventional medicine. The computerized 
reimbursement database of the NHI stores longitudinal data of 
the beneficiaries of both Western and Chinese medicines, thus 
providing an optimal platform for determining the utilization 
pattern of CHPs and conventional drugs concurrently. These data 
provide important information on Taiwan’s experience for policy 
makers of other countries who seriously consider the recom-
mendations of integrating traditional medicine into the national 
health system by the World Health Organization.[1]
The present study indicates that more than one of every ten pa-
tients receiving conventional drugs that were prescribed by their doc-
tors still sought for TCM and received CHP prescription on the same 
day in 2007. Furthermore, the present data also show that more than 
94% of the patients who simultaneously used both a conventional 
drug and a CHP received the drug and CHP from different locations. 
This finding indicates that most doctors of conventional medicine 
do not know from patient charts what herbs their patients consume 
and for what reasons their patients want to add Chinese herbs to 
their regular conventional medicine, which may result in a potential 
herb–drug interaction and lead to an unpredictable efficacy.[5-10] We 
actually knew very little about herbs and their potential for inter-
action with drugs; therefore, these incidents could be only the tip 
of the iceberg. Healthcare providers and public health and policy 
analysts should give greater attention to this particular healthcare 
Table 4. Top five co-prescribed Chinese herbal products and conventional drugs, by case and co-prescription frequency, 2007
Drug‑CHP Total no. of 
cases (%)
Total no. of 
co‑prescriptions (%)
Average no. of 
co‑prescriptions per person
Total 120,729 (100) 845,103 (100) 7.0
Acetaminophen* 34,217 (28.3) 123,307 (4.1) 3.6
SH: Corydalis Rhizoma 7289 (6) 10,426 (0.3) 1.4
HF: Supplemented Free Wanderer Powder 6948 (5.8) 10,754 (0.4) 1.5
Diclofenac* 13,045 (10.8) 85,363 (2.8) 6.5
SH: Salviae Miltiorrhiza Radix 5706 (4.7) 9342 (0.3) 1.6
HF: Channel‑Coursing Blood‑Quickening Decoction 6033 (5) 8782 (0.3) 1.5
Dextromethorphan† 13,927 (11.5) 67,778 (2.3) 4.9
SH: Fritillariae Bulbus 6323 (5.2) 8924 (0.3) 1.4
HF: Pueraria Decoction 5683 (4.7) 7546 (0.3) 1.3
Ambroxol† 8202 (6.8) 67,641 (2.3) 8.2
SH: Puerariae Radix 6573 (5.4) 8707 (0.3) 1.3
HF: Ephedra, Apricot Kernel, Licorice, and Gypsum Decoction 6009 (5) 7399 (0.2) 1.2
Ibuprofen* 8396 (7) 54,572 (1.8) 6.5
SH: Glycyrrhizae Radix (Gan cao) 5638 (4.7) 8316 (0.3) 1.5
HF: Pinellia Heart‑Draining Decoction 4821 (4) 7184 (0.2) 1.5
*An analgesic (also known as a painkiller) is any member of the group of drugs used to relieve pain. †A cough medicine is a medicinal drug used in an 
attempt to treat coughing and related conditions
Lai, et al. / Journal of Traditional and Complementary Medicine 3 (2013) 256‑262
261
seeking behavior and should assess the potential long-term impact 
on health outcomes among this population.
Characteristics of concurrent users
The present study found that frequent TCM users such as 
females and individuals with a regular salary income[18-20,24-33] 
were more likely to consume CHPs and conventional drugs 
concurrently than males and those in the low-income group. As 
compared to patients living in Northern Taiwan, patients living 
in Central, Southern, or Eastern Taiwan were more likely to be 
a concurrent user. Possibly, Taiwan’s earliest settlers who had 
come from mainland China introduced TCM into the southern 
part of Taiwan, which became the major health care of Southern 
Taiwan in the early 17th century. The present data also show that 
the co-administration peaked over 64 years of age, followed by 
the 55-64 and 45-54 years age groups, which was in contrast to 
the distribution of the D-alone group. Among the elderly users of 
conventional medicine, approximately one out of five, at some day 
during the study period in Taiwan, consumed herbs concurrently 
intending to relieve their discomfort from an upper respiratory 
infection or hypertension or from diseases of symptoms, signs, 
and ill-defined conditions. A previous study has proposed that 
the public and physicians require more education concerning 
the inappropriate use of conventional drugs by the elderly in 
Taiwan.[34-36] The results of the present study suggest that without 
setting up an integrative system to fully communicate between 
systems of TCM and conventional medicine, the add-on pre-
scriptions of TCM might further produce complications among 
the elderly population. Further studies are warranted to provide 
information for the safe use of TCM interventions in conjunction 
with conventional medicine among the elderly.[37,38]
In contrast to the utilization pattern of the D-alone group, the 
present data show that diseases of the blood and blood-forming 
organs (ICD-9 codes 280-289), congenital anomalies (ICD-9 codes 
740-759), and diseases of the symptoms, signs, and ill-defined condi-
tions (ICD-9 codes 780-799) were the top three categories of patients 
with a high proportion that consumed a CHP and a conventional 
drug on the same day in Taiwan.[39] Ancient Chinese medicine theory 
encourages women taking Chinese herbal medicine to build up their 
blood supply in order to reserve strength for each menstruation cycle 
because women expect a significant amount of blood to be lost dur-
ing that.[40,41] The anemia-related fatigue, dizziness, and palpitations 
might be the major reasons that lead to the patient’s behavior of 
seeking TCM and receiving prescriptions of conventional drugs and 
CHPs concurrently. Similar to the diseases of the symptoms, signs, 
and ill-defined conditions, congenital anomalies often present physi-
cal problems not easily resolved, which tend to increase patient’s and 
family’s anxiety, leading to concurrent use of conventional drugs 
and complementary treatments. To avoid herb–drug interaction, 
we recommend the establishment of integrative approach between 
conventional medicine and TCM in the future, beginning with the 
above three major categories of diagnosis.
The most common concurrent drugs and CHPs
Table 4 shows that pain killers and cough medicines were among 
the most frequent drugs co-prescribed with CHPs. Over one-fourth 
of the CH + D group had taken acetaminophen. Among these con-
current users, Corydalis Rhizoma was the most common Chinese 
single herb that, according to the documentation of ancient Chinese 
medicine book, can relieve pain in any part of the body resulting 
from Qi stagnation and blood stasis. In addition, a previous clini-
cal trial indicated that Supplemented Free Wanderer Powder (加
味逍遙散 Jiā Wèi Xiāo Yáo Sǎn), which was the most commonly 
prescribed Chinese formula in acetaminophen users, might be an 
alternative choice for relief of somatic symptoms in postmenopausal 
women. Similarly, Fritillariae Bulbus (貝母 Bèi Mǔ) or Pueraria 
Decoction (葛根湯 Gé Gēn Tang) and Puerariae Radix (葛根 Gé 
Gēn) or Ephedra, Apricot Kernel, Licorice, and Gypsum Decoction 
(麻杏甘石湯 Má Xìng Gān Shí Tāng) were often prescribed for 
treating cough and reducing sputum retention by TCM doctors. 
Therefore, the concerns regarding herb–drug interactions cannot be 
overlooked; thus, further study on the safety and efficacy of such 
concurrent use of conventional drugs and CHPs is warranted.[43]
Limitations
Our study has three limitations. First, NHI only reimburses 
CHPs; decoction is not reimbursed and, therefore, not included and 
cannot be generalized as to its usage. Second, this study did not 
include Chinese herbal remedies purchased directly from the phar-
macies of TCM, nor did it include health food containing herbs. 
Thus, the frequency of concurrent use of conventional medicine 
and CHP might have been underestimated. However, because the 
NHI system has a comprehensive coverage and the copayment for 
prescriptions is universally NT$ 50 (new Taiwan) (approximately 
equal to US$ 1.5), which is generally less than the cost of herbs 
sold in Taiwan’s markets, the likelihood that the subjects purchased 
many other herbs outside of the NHI database is not high.
CONCLUSION
In summary, under the co-existence of the conventional 
medicine system and Chinese medicine system, this study found 
that concurrent use of the drugs and CHP was high in Taiwan. 
Acetaminophen was the most frequently prescribed painkiller to be 
used in combination with CHP. The present data provide up-to-date 
information for all physicians and TCM practitioners concerning 
the safety of co-administration of pain killers and CHPs. Thus, we 
recommend that to optimize the health care of our patients under 
limited resources, policy makers should implement their plans to 
allow integration of two separate healthcare systems. Addition-
ally, we recommend that countries that plan to integrate traditional 
medicine into the modern healthcare system should set strategies 
to minimize the potential drug–herb interactions at the very early 
beginning of the development of integrative medicine.
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